6533b852fe1ef96bd12ab84f
RESEARCH PRODUCT
Amyloidosis and device therapy: an open debate
Giuseppe CoppolaSalvatore NovoGiuseppe IngaEgle CorradoEluisa La FrancaGianfranco Ciaramitarosubject
medicine.medical_specialtyDevice therapybusiness.industryAmyloidosismedicineAmyloidosisCardiology and Cardiovascular Medicinemedicine.diseaseIntensive care medicinebusinessdescription
Cardiac involvement represents a critical prognostic factor in amyloidosis, as it represents a leading cause of morbidity and mortality, in primary light chain amyloidosis, in hereditary and also in wild-type transthyretin amyloidosis. A 54-year-old male was admitted to Emergency Room with complaints of dyspnea, palpitations and diaphoresis.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2017-07-01 | International Angiology |